
Voglicip 0.3 Tablet
Marketer
Cipla Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglicip 0.3 Tablet
Diabetic patients with type 2 diabetes mellitus may find relief with the medication, Voglicip 0.3mg Tablets. This medication assists in regulating elevated postprandial blood glucose levels. It's prescribed when dietary modifications and other similar antidiabetic treatments prove insufficient to manage hyperglycemia. Administer Voglicip 0.3mg Tablets immediately prior to meals. Dosage frequency and strength are determined by your physician to optimize glycemic control. Abrupt cessation without medical consultation is strongly discouraged; this could lead to dangerously elevated blood sugar, potentially resulting in severe complications, including renal impairment and vision loss. This medication forms part of a comprehensive treatment plan which necessitates a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial during treatment. Common adverse reactions include gastrointestinal discomfort (flatulence, abdominal pain, anorexia, constipation, diarrhea). Report persistent or bothersome side effects to your physician. While Voglicip 0.3mg Tablets alone do not cause hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) elevates this risk. Should hypoglycemia occur, treat with plain glucose; ordinary table sugar is ineffective. Prior to initiating treatment, disclose any kidney or liver conditions to your doctor. This medicine is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals should seek medical counsel before use. Inform your doctor of all concomitant medications to ensure safety. Excessive alcohol consumption should be avoided as it may increase the risk of hypoglycemia.
Uses of Voglicip 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Voglicip 0.3 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglicip 0.3 Tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.
Common Side effects of Voglicip 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglicip 0.3 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglicip 0.3 Tablet on an empty stomach.
How Voglicip 0.3 Tablet works:
Voglicip 0.3mg tablets are used to manage diabetes. They work by blocking the enzymes in the intestines that digest complex carbohydrates into simple sugars like glucose, thus preventing post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglicip 0.3 Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Voglicip 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals have indicated minimal or no harmful consequences for the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglicip 0.3 Tablet without significant risk to their infants. Available human data indicate minimal danger to the baby.
DrivingSAFE
Driving ability is typically unaffected by Voglicip 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Voglicip 0.3 Tablets. Dosage modification of Voglicip 0.3 Tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglicip 0.3 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglicip 0.3 Tablet :
Omit any missed Voglicip 0.3 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Voglicip 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
